Halda Therapeutics Raises $126M For RIPTAC Cancer Therapies
12 Aug 2024 //
BUSINESSWIRE
Halda Therapeutics Publishes RIPTAC™ Proof-Of-Mechanism For Cancer Treatment
07 Aug 2024 //
BUSINESSWIRE
Halda Therapeutics Presents Preclinical Data for RIPTAC™ Therapeutics
17 Apr 2023 //
BUSINESSWIRE